Fourteen laboratories interested in the analysis of human hair for drugs of abuse participated in a fourth interlaboratory study to determine how well drugs could be detected and quantitated in hair. The drugs of abuse included cocaine, benzoylecgonine, cocaethylene, codeine, morphine, and 6-monoacetylrnorphine. The hair samples analyzed were in the form of short segments and included hair from drug users, soaked hair (drug-free hair into which drugs had been soaked), and drug-free hair. Results from the study show that the laboratories performed well qualitatively, but that there was a large amount of scatter in quantitative results. Various methods were used to extract the drugs from the hair, and the most commonly used approaches, HCI extractions, methanol extractions, and enzyme digestions, all gave comparable results. Gas chromatography-mass spectrometry (GC-MS) was the most commonly used analytical technique. Of the laboratories using GC-MS, some produced consistently good results, whereas others produced results of poorer quality. Two laboratories using liquid chromatography-mass spectrometry produced good results, but the one laboratory using liquid chromatography without mass spectrometric detection produced less accurate results. Laboratories that reported good results on control material sent with the unknowns generally performed better on the unknowns than did laboratories whose results on the control were less accurate.
Introduction
Laboratories throughout the world are investigating the use of hair analysis for detecting illegal drug use. As with any new analytical approach that may be used for determining drug use, laboratories must demonstrate that they can reliably determine which samples have drugs and which are drug-free. Interlaboratory studies can shed some light on how well laboratories can make this distinction. This paper describes the fourth interlaboratory study undertaken at the National Institute of Standards and Technology (NIST) on the analysis of hair for drugs of abuse. The goals of these studies are to determine the following: how well drugs can be detected and quantitated in hair, which extraction and measurement technologies perform best, below what concentrations of drugs in hair does laboratory performance decline (to help establish possible cutoff levels), and how well laboratories can detect and correct for external contamination. The research program at NIST has been described in detail elsewhere (1) , as have the results from previous exercises (2, 3) . Other interlaboratory comparisons for drugs of abuse in hair have also been published (4, 5) .
Experimental

Instructions to laboratories
The participating laboratories were given instructions regarding the analysis of the hair samples and a list of compounds for which they would be testing. For quantitative purposes, sampies were not to be washed prior to analysis. We recommended that sample size be a minimum of 10 mg to reduce possible within-vial inhomogeneity. The laboratories were free to use whatever methods they chose for extraction and analysis. We did request that they use a GC-MS method for the quantitative analysis, if possible. The laboratories were asked to test a portion of each sample for evidence of external contamination and, if possible, estimate its contribution to the total drug found. A sample of NIST RM 8448, Drugs of Abuse in Human Hair Segments, was included with the unknowns and reference values were included for the compounds present. The laboratories were asked to report their results on this reference material. The laboratories were informed that they would receive feedback as to how their performance compared with the overall performance of the group, but no laboratory would be given information about the particular performance of any other laboratory.
Sources of hair
The hair samples which were used in this interlaboratory study consisted of 50-80 mg each of drug users' hair (samples 1, 4, 6, and 8), fortified hair (drug-free hair into which drugs had been soaked; samples 2 and 7), and drug-free hair (samples 3 and 5). The analytes known to be in the samples are shown in Table I . The drug users' hair samples were obtained from laboratories in the United States and Europe. The fortified hair was obtained by soaking drug-free hair in a 1:1 dimethylsulfoxide-water solution of cocaine (COC), benzoylecgonine (BZE), and cocaethylene (CE), or in a dimethylsulfoxide solution of codeine (COD), morphine (MOR), and 6-monoacetylmorphine (6-MAM). The drug-free hair samples, which were used for preparing fortified hair and for blanks in the study, were obtained from volunteers at NIST. All the hair samples were manually cut with scissors into short lengths (2-5 ram).
Analytical methods used by the participating laboratories
The participating laboratories provided general information about their methods. The sample sizes used varied from 2 to 50 mg with the smaller sample sizes used for radioimmunoassay (RIA) screening by some laboratories. Washing procedures varied widely among the laboratories. Various organic solvents were used, including methanol, ethanol, isopropanol, acetone, dichloromethane, and petroleum ether. Other laboratories used combinations of organic solvents and water, phosphate buffer, and non-ionic detergents.
The methods that were used to liberate the drugs from the hair included dilute hydrochloric acid extractions (6 labs), methanol extractions (4 labs), buffer-enzyme digestions (3 labs), and base, 2 mol/L NaOH (1 lab, analyzing for opiates only). The dilute acid extractions were generally warmed gently, from room temperature to 56~ for 18 to 24 h. The methanol extractions were also warmed at 45-50~ for 5 to 18 h. Buffer-enzyme digestions were carried out at 37 or 40~ with proteinase K or ~-glucuronidase-arylsulfatase, respectively.
For sample cleanup after extraction, most of the laboratories used solid-phase extraction. Two of the laboratories used liquid-liquid extraction. Three of the laboratories that used methanol extraction did not perform any additional sample cleanup.
The most commonly used measurement method was gas chromatography-mass spectrometry (GC-MS), which was used by eleven of the laboratories. Two of the laboratories used liquid chromatography-mass spectrometry (LC-MS), and one used high-pressure liquid chromatography (HPLC) with fluorometric or electron conductivity detection. Two of the laboratories used RIA for screening purposes prior to GC-MS analyses.
Analytical methods used at NIST (1)
Samples of hair (10-30 rag) were weighed into screw-capped vials. To each vial were added sufficient deuterated internal standards to give an unlabeled:labeled ratio near 1 for each drug to be determined in the sample and 2 mL of 0.1 mol/L HCI. The samples were then heated at 45~ for 20-24 h. Solutions for the determination of COC, CE, and BZE were neutralized with 1 mol/L KOH to pH 6, and then 2 mL of 0.1 mol/L phosphate buffer (pH 6) was added to each. Solutions for the determination of morphine and codeine were neutralized with 1 mol/L KOH to a pH of 7-8. Each sample was put through a solid-phase extraction cartridge designed for urine drug testing according to the manufacturer's directions for the same analytes in urine samples. The eluates were dried under nitrogen and were dissolved in neat N,O-bis-(trimethylsilyl)acetamide (BSA).
A different approach was used for the determination of 6-MAM in hair samples. After samples were spiked with the deuterated material, they were extracted with 2 mL of methanol at 45~ for 24 h. The samples were dried under * Number of laboratories reporting a positive result. t Number of laboratories reporting a negative result. * Abbreviations: COD = codeine; MOR = morphine; 6-MAM = 6-monoacetylmorphine; COC = cocaine; BZE = benzoylecgonine; CE = cocaethylene.
nitrogen, dissolved in water, and put through a solid-phase extraction cartridge following the directions for morphine and codeine. The eluates were dried under nitrogen, and the residues were dissolved in neat N-methyl-bis-(trifluoroacetamide) (MBTFA) and heated at 60~ for 1 h. The samples were analyzed by selected-ion-monitoring GC-MS, using a gas chromatograph with a 30-m, fused-silica, nonpolar capillary column and a quadrupole MS operated in the electron ionization mode. The ion pairs monitored were 182/185 for COC, 240/243 for BZE, 371/374 for COD, 429/432 for MOR, 196/199 for CE, and 364/367 for 6-MAM. Standard curves were determined for each material with standards prepared from the unlabeled and labeled drugs.
Results and Discussion
Results were received from 14 laboratories, including NIST. As promised, each participant was sent information about its performance versus the overall performance of the group. One important measure of performance was how well the laboratories identified the analytes present in the samples. There were a total of 16 positive challenges in this exercise for laboratories that analyzed for all 6 analytes. That is, among the 8 samples were a total of 16 instances where a drug was present. The sixteen positive challenges are listed in Table I with the numbers of laboratories reporting positive and negative results, the interlaboratory means and coefficients of variation (CV), the ranges, and the outliers. For this study, outliers are defined as those results that differed by more than a factor of 3 from the mean value. Conversely, there were 32 negative challenges. Laboratories were assessed based upon the number of positive and negative challenges they had for the analytes for which they analyzed the hair samples. Five laboratories had all 16 positive challenges; one laboratory had only 4 positive challenges and 12 negatives.
Positives on negative challenges
The finding of false positives is a matter of great concern for the drug-testing community because of the effects that false positives can have on people's lives. In this fourth interlaboratory study, the incidence of positives reported on drug-free hair samples was higher than had been found on previous exercises (2, 3) . There were 12 instances total from 5 laboratories when drugs reported as present were not present in drug-free hair samples. There was also one positive result reported for cocaine found in a drugfree sample that had been fortified with opiPercent ates but contained no cocaine. These posioutliers tives would be false positives only if the levels reported were above predetermined 6.5 cut-off levels. Nine laboratories had no er-9.8 roneous positives. 10.0
The drug use histories were not known 8.0
for the individuals whose hair was included 10. 5 as that of a drug user. Therefore, when a few 17.6 laboratories report a drug as present in one of these samples when the majority of laboratories do not, it is possible that the drug could be present, but not homogeneously distributed. We cut the hair into short segments and attempted to mix it, but it is not possible to ensure that every sample is equivalent. For this exercise, there were nine instances of such reports. Seven of these were from one sample and involved all three opiates included in this study. However, the five laboratories making these reports were the same five laboratories that reported drugs in drug-free samples. Therefore, these reported positives are probably erroneous. Of the 22 total positive reports on negative challenges, 9 were reported at concentrations below 0.5 ng/mg, 3 were in the range of 0.5-0.9 ng/mg, 8 were in the range of 1.0-2.0 ng/mg, and 2 were above 2 ng/mg. Thus, at a cutoff of 1 ng/mg, there were 10 reported false positives; at a cutoff of 2 ng/mg, the number of false positives dropped to 2.
Negatives on positive challenges
There were 23 instances of laboratories reporting that they did not find a particular analyte in a sample for which the majority of laboratories reported a positive result. Nineteen of * Abbreviations: SD = standard deviation; CV = coefficient of variation, these were from drug users' hair, and four were from fortified hair samples. The number of misses by laboratories ranged from 0 to 4 with three laboratories having no misses (2 of these 3 did not analyze for all of the drugs) and one laboratory having 4 misses. The misses were associated with low drug concentrations. For drug levels below 1 ng/mg, positives were reported only 71% of the time, compared with 90% for drug levels of 1-2 ng/mg and 95% for drug levels greater than 2ng/mg.
Quantitative results
The interlaboratory scatter in the quantitative results was high. Even after outliers that were more than a factor of three from the mean were excluded, CVs ranged from 5 to 70% for each sample/analyte with a mean CV of 42%. There were 15 outliers, which were spread almost equally over all the analytes with a slightly higher incidence for the drug users' samples.
The CVs were nearly equally high regardless of analyte, level, or if the sample was from a drug user or was a fortified sample.
If those results that were more than a factor of 2 from the mean were excluded, the number of outliers would approximately double, but the mean CV would drop to 31%.
New analytes
This fourth exercise added two analytes, CE and 6-MAM, that had not been included in previous exercises. Only five laboratories measured CE, and ten measured 6-MAM. The results are summarized by analyte in Table II . There are no large differences in qualitative laboratory performance among the analytes, although performance was somewhat worse on positive challenges for BZE, COD, and 6-MAM. 
Use of reference materials
One important tool that a laboratory can use to determine the accuracy of their methods is reference materials. Laboratories were asked to measure COC, BZE, MOR, and COD in RM 8448, Drugs of Abuse in Human Hair Segments, and compare their results with the reference values for this material. Table  III shows the results of the analysis of RM 8448. Ten laboratories reported results on RM 8448. Both NIST and participant analyses showed that the COC, COD, and MOR concentrations in the sample had decreased slightly since its certification in December 1991, and the BZE concentration had increased slightly, probably from the decomposition of cocaine. However, a few laboratories reported values that were greatly different from the reference values and the means of the participants. The relationship between discordant results on RM 8448 and errors on positive specimens (either negatives or outliers) for each laboratory is shown in Figure 1 . These data demonstrate that the laboratories that had the largest mean differences (absolute values) from the reference values also had the highest error rate on positive challenges.
Because the concentrations of drugs in Reference Material 8448 had changed with time, Hair Powder Reference Material 8449 was also analyzed by NIST, but not by the participants. The analyses showed that COC, COD, and MOR concentrations had not changed significantly since the material was certified in June 1991 and that the BZE concentration appeared to be somewhat higher than had been measured previously.
Extraction and analysis techniques
Another purpose of this interlaboratory study was to determine if results from one technique for extracting drugs from hair were better than those from other techniques. Examinination of the results from the different techniques showed that it was not possible to conclude that one approach gave better results than the others (Table IV) . Previous studies have found similar mixed results with the different extraction approaches (3). These findings indicate that good laboratory technique and good quality control are more important for achieving good results than the particular approach chosen for extraction.
Most of the laboratories used GC-MS for analyzing the extracts, and their performance varied considerably. From the limited results using other measurement techniques, it appears that the LC-MS results are indistinguishable from those Journal of Analytical Toxicology, Vol. 20, July/August 1996 laboratories with good GC-MS results. The LC results for this exercise were not as good; there were an above average number of instances of positives on negative challenges and outliers on the positive challenges. In previous exercises, LC methods generally produced satisfactory results.
External contamination
In this exercise, we attempted to assess how well laboratories could detect external contamination. The number of laboratories reporting external contamination for each sample is shown in Table V . These results demonstrate that unless the contamination is very heavy, as was the case for sample 8, there is no consensus among the laboratories as to which samples are externally contaminated. All of the samples with drug present are subject to some extraction of drugs with various solvents used for washing. The fortified hair may be more prone to extraction by washing solvents than the drug users' samples, but the results in Table V do not bear this out. There is no reason to suspect that the blank samples were externally contaminated; the two instances reported were probably laboratory error, perhaps through inadvertent contamination in the processing steps.
Fortified versus drug users' hair
There are certain advantages to using fortified hair instead of drug users' hair for interlaboratory studies. It is possible to produce relatively large batches of hair with uniform concentrations of the target analytes. However, these hair samples do not exactly mimic drug users' hair. Results of this exercise, shown in Table VI , generally agree with results from earlier exercises in that laboratory performance on these samples is somewhat better than it is on drug users' hair. The distribution of drugs is probably much more uniform along the hair and among the hairs for fortified hair. The cross-sectional distribution may be significantly different between these two types, and thus may extract more easily from one type than from the other, at least by some extraction methods.
Summary of the First Four Interlaboratory Exercises
Four exercises have now been completed. The number of participating laboratories has increased with each exercise as has the challenge for the laboratories. A total of twenty labo- ratories, not counting NIST, have participated in one or more exercises. Five of the twenty have participated in all four exercises. The first exercise consisted of powdered hair with relatively high drug levels, and the samples were tested for only three analytes. Subsequent exercises have used only hair segments with most of the concentrations being less than 2 ng/mg and have added analytes. A summary of the four exercises is shown in Table VII . From our interpretation of the results from these studies, we have made some conclusions on the ability of laboratories to detect and measure drugs of abuse in hair. Some laboratories have consistently performed well on all the exercises, which proves that accurate results are possible. Qualitatively, the overall performance across the four exercises has been good with low rates of positives reported on negative challenges. Such positives may result from failure of the laboratories to follow good quality control procedures, such as frequently running drug-free hair samples to ensure that no contamination is occuring in the laboratory. As expected, the ability of laboratories to detect drugs decreases with concentration. Therefore, any cut-off level established will have to take into account that an acceptable balance between false positives and false negatives will have to be determined. Quantitative results are highly scattered, in part because of different washing and extraction procedures, and also because of the differences in experience and adherence to quality assurance procedures. Interlaboratory studies should continue in order to monitor the changing state of the art, to better define cut-off levels, to test the strengths and limitations of hair analysis, and to provide laboratories with feedback on their performance.
